Onion Polyphenols as Multi-Target-Directed Ligands in MASLD: A Preliminary Molecular Docking Study
-
Published:2024-04-20
Issue:8
Volume:16
Page:1226
-
ISSN:2072-6643
-
Container-title:Nutrients
-
language:en
-
Short-container-title:Nutrients
Author:
Paravati Maria Rosaria1ORCID, Procopio Anna Caterina1ORCID, Milanović Maja2ORCID, Scarlata Giuseppe Guido Maria1ORCID, Milošević Nataša2ORCID, Ružić Maja3, Milić Nataša2, Abenavoli Ludovico1ORCID
Affiliation:
1. Department of Health Sciences, University “Magna Graecia”, 88100 Catanzaro, Italy 2. Department of Pharmacy, Faculty of Medicine Novi Sad, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia 3. Faculty of Medicine, University of Novi Sad, Clinic for Infectious Diseases, University Clinical Centre of Vojvodina, Hajduk Veljkova 1, 21000 Novi Sad, Serbia
Abstract
A sedentary lifestyle associated with unregulated diets rich in high-calorie foods have contributed to the great prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) latterly, with up to 60% in the high-risk population and 25% in the general population. The absence of specific pharmacological strategies for this syndrome represents one of the major problems in the management of MASLD patients. Lifestyle interventions and adherence to a healthy diet are the main cornerstones of current therapies. The identification of nutraceuticals useful in the treatment of MASLD appears to be one of the most promising strategies for the development of new effective and safe treatments for this disease. The onion, one of the most widely studied foods in the field of nutraceuticals, serves as an inexhaustible reservoir of potent compounds with various beneficial effects. The following preliminary study analyzes, mediating in silico studies, the iteration of a library of typical onion compounds with 3-hydroxy-3-methylglutaryl-coenzyme A reductase, liver receptors X α and β, as well as peroxisome proliferator-activated receptors α and γ. In this study, for the first time promising smart molecules from the onion that could have a beneficial action in MASLD patients were identified.
Funder
Provincial Secretariat for Higher Education and Scientific Research, AP Vojvodina, Republic of Serbia
Reference56 articles.
1. Nonalcoholic fatty liver disease;Schaffner;Prog. Liver Dis.,1986 2. Abenavoli, L., Giubilei, L., Procopio, A.C., Spagnuolo, R., Luzza, F., Boccuto, L., and Scarpellini, E. (2022). Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay. Nutrients, 14. 3. Beneficial effects of coffee in non-alcoholic fatty liver disease: A narrative review;Procopio;Hepatoma Res.,2020 4. The role of gluten-free diet in nonalcoholic fatty liver disease development;Larussa;Eur. Rev. Med. Pharmacol. Sci.,2021 5. Abenavoli, L., Procopio, A.C., Paravati, M.R., Costa, G., Milić, N., Alcaro, S., and Luzza, F. (2022). Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease. J. Clin. Med., 11.
|
|